CVS Health Corporation $CVS Stock Acquired by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. increased its holdings in CVS Health Corporation (NYSE:CVS) by 4.1% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 2,091,736 shares of the pharmacy operator’s stock after buying an additional 82,976 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in CVS Health were worth $179,241,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CVS. 55 North Private Wealth LLC raised its stake in CVS Health by 16.3% during the third quarter. 55 North Private Wealth LLC now owns 5,120 shares of the pharmacy operator’s stock worth $439,000 after acquiring an additional 719 shares in the last quarter. Flagship Capital Management Inc. boosted its stake in shares of CVS Health by 1.1% in the 3rd quarter. Flagship Capital Management Inc. now owns 29,198 shares of the pharmacy operator’s stock valued at $2,502,000 after purchasing an additional 319 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in shares of CVS Health by 0.7% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 191,455 shares of the pharmacy operator’s stock valued at $16,406,000 after purchasing an additional 1,395 shares in the last quarter. Grant Private Wealth Management Inc acquired a new stake in shares of CVS Health in the 3rd quarter valued at $678,000. Finally, SteelPeak Wealth LLC grew its holdings in shares of CVS Health by 1,168.7% in the 3rd quarter. SteelPeak Wealth LLC now owns 30,410 shares of the pharmacy operator’s stock worth $2,606,000 after purchasing an additional 28,013 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Opportunity to gain pharmacy customers: CVS is targeting customers displaced by Walgreens and Rite Aid store closures. The initiative could support prescription volume, retail sales and customer retention if CVS successfully converts those patients. CVS targets former Walgreens, Rite Aid customers after 1,000 stores close
• Positive Sentiment: Aetna administrative improvements: CVS says Aetna is streamlining prior authorizations, approving more than 95% of eligible requests within 24 hours and expanding bundled approvals. Faster decisions could improve member and provider satisfaction while reducing administrative costs. How CVS’ Aetna Is Advancing Efforts to Reduce Administrative Burden
• Positive Sentiment: MinuteClinic expansion: Three new Massachusetts locations—including the first in Boston—expand CVS’s healthcare footprint and may increase patient traffic, service revenue and cross-selling opportunities. MinuteClinic opens three new retail medical clinics
• Neutral Sentiment: Leadership transition: Chief Information Officer Amaresh Siva is leaving CVS to become Alaska Airlines’ chief information technology officer. The departure may create near-term technology and AI execution uncertainty, though it does not directly change CVS’s financial outlook. Alaska Airlines taps CVS Health executive for new technology role
• Negative Sentiment: Industry and valuation concerns: Coverage highlights pressure from rising medical costs across managed care, uncertainty surrounding Medicare Advantage plan availability and technical weakness after CVS raised its outlook. These issues could limit valuation expansion despite the company’s improved earnings guidance. Management raised the bar for CVS Health stock

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Argus lifted their price target on shares of CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a report on Wednesday, August 19th. Barclays upped their price objective on shares of CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Wells Fargo & Company increased their price target on CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Truist Financial raised their target price on CVS Health from $108.00 to $118.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and set a $112.00 price target on shares of CVS Health in a research report on Wednesday, September 9th. Twenty equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $107.80.

CVS Health Price Performance

CVS opened at $94.77 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The stock has a market capitalization of $121.21 billion, a P/E ratio of 25.07, a price-to-earnings-growth ratio of 0.86 and a beta of 0.60. The company’s 50 day simple moving average is $91.70 and its 200-day simple moving average is $93.49. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd will be paid a $0.6650 dividend. The ex-dividend date of this dividend is Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. CVS Health’s dividend payout ratio is 70.37%.

CVS Health Company Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.